ICO — Iconovo AB Share News
0.000.00%
Last trade - 00:00- SEK104.83m
- SEK66.64m
- SEK1.10m
Brief: Iconovo April-June Operating Widens Loss To SEK 12.2 mln
Brief: Iconovo Q2 Operating Loss Widens To SEK 12.2 Million
Brief: Iconovo Receives Additional Patent For Icores In EU
Brief: Iconovo Granted Patent In Japan
Brief: Iconovo Updates Its Long-Term Financial Targets
Brief: Iconovo Q1 Operating Loss Widens To SEK 9.5 Million
Brief: Iconovo And Galenica Enters Strategic Collaboration For Development Of New Inhalation Products
Brief: Iconovo Q1 Operating Loss Widens To SEK 9.5 Mln
Brief: Iconovo Extends Collaboration With ISR
Brief: Iconovo Expands Cooperation With ISR With Supplementary Deal
Brief: Iconovo Q4 Net Sales Lower To SEK 3.6 Mln
Brief: Iconovo Q4 Operating Loss Widens To SEK 8.7 Million
Brief: Iconovo Completes Study Of Icores Budesonide/Formoterol
Brief: Iconovo Establishes Iconovo Pharma As Subsidiary For Pharmaceutical Sales In Nordic Countries
Brief: Iconovo Signs Agreement With Japanese TOA Pharmaceuticals
Brief: Iconovo And TOA Sign Agreement For Development Of Generic Product
Brief: Iconovo Gets First Icoone Patent Granted In China
Brief: Iconovo Q3 Operating Loss Widens To SEK 3.9 Mln
Brief: Iconovo: Second Icores Patent Granted In Japan